Resolvin D1 inhibits TGF-β1-induced epithelial mesenchymal transition of A549 lung cancer cells via lipoxin A4 receptor/formyl peptide receptor 2 and GPR32

International Journal of Biochemistry and Cell Biology

Volumn 45, Issue 12, 2013, Pages 2801-2807

  Lee, Hye Ja ^a   Park, Mi Kyung ^a   Lee, Eun Ji ^a   Lee, Chang Hoon ^a  

^a Dongguk University   (South Korea)

Author keywords

A549 lung cancer cell; Lipoxin A4 receptor formyl peptide receptor 2; N cadherin expression; Resolvin; TGF 1 induced epithelial mesenchymal transition

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ANTINEOPLASTIC AGENT; FORMYLPEPTIDE RECEPTOR LIKE 1; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 32; MESSENGER RNA; NERVE CELL ADHESION MOLECULE; RESOLVIN D1; RESOLVIN D2; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR SNAIL; TRANSCRIPTION FACTOR ZEB1; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN;

ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL CONTACT; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; GENE SILENCING; HUMAN; HUMAN CELL; LUNG CANCER; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

A549 LUNG CANCER CELL; LIPOXIN A4 RECEPTOR/FORMYL PEPTIDE RECEPTOR 2; N-CADHERIN EXPRESSION; RESOLVIN; TGF-Β1-INDUCED EPITHELIAL MESENCHYMAL TRANSITION;

CELL LINE, TUMOR; DOCOSAHEXAENOIC ACIDS; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; LIPOXINS; LUNG NEOPLASMS; RECEPTORS, FORMYL PEPTIDE; RECEPTORS, G-PROTEIN-COUPLED; RNA, SMALL INTERFERING; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84886737097     PISSN: 13572725     EISSN: 18785875     Source Type: Journal    
DOI: 10.1016/j.biocel.2013.09.018     Document Type: Article

References (34)

1. A.F. Bento, R.F. Claudino, R.C. Dutra, R. Marcon, and J.B. Calixto Omega-3 fatty acid-derived mediators 17(R)-hydroxy docosahexaenoic acid, aspirin-triggered resolvin D1 and resolvin D2 prevent experimental colitis in mice J Immunol 187 2011 1957 1969
2. N. Chiang, I.M. Fierro, K. Gronert, and C.N. Serhan Activation of lipoxin A(4) receptors by aspirin-triggered lipoxins and select peptides evokes ligand-specific responses in inflammation J Exp Med 191 2000 1197 1208
3. C.E. Denlinger, J.S. Ikonomidis, C.E. Reed, and F.G. Spinale Epithelial to mesenchymal transition: the doorway to metastasis in human lung cancers J Thorac Cardiovasc Surg 140 2010 505 513
4. V.A. Fadok, D.L. Bratton, A. Konowal, P.W. Freed, J.Y. Westcott, and P.M. Henson Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF J Clin Invest 101 1998 890 898 (Pubitemid 28096086)
5. C.G. Freire-de-Lima, Y.Q. Xiao, S.J. Gardai, D.L. Bratton, W.P. Schiemann, and P.M. Henson Apoptotic cells, through transforming growth factor-beta, coordinately induce anti-inflammatory and suppress pro-inflammatory eicosanoid and NO synthesis in murine macrophages J Biol Chem 281 2006 38376 38384 (Pubitemid 46041961)
6. R.M. Gemmill, J. Roche, V.A. Potiron, P. Nasarre, M. Mitas, and C.D. Coldren ZEB1-responsive genes in non-small cell lung cancer Cancer Lett 300 2011 66 78
7. J.J. Hung, M.H. Yang, H.S. Hsu, W.H. Hsu, J.S. Liu, and K.J. Wu Prognostic significance of hypoxia-inducible factor-1alpha, TWIST1 and Snail expression in resectable non-small cell lung cancer Thorax 64 2009 1082 1089
8. H. Ikushima, and K. Miyazono TGFbeta signalling: a complex web in cancer progression Nat Rev Cancer 10 2010 415 424
9. D.S. Im Omega-3 fatty acids in anti-inflammation (pro-resolution) and GPCRs Prog Lipid Res 51 2012 232 237
10. M. Kawata, D. Koinuma, T. Ogami, K. Umezawa, C. Iwata, and T. Watabe TGF-beta-induced epithelial-mesenchymal transition of A549 lung adenocarcinoma cells is enhanced by pro-inflammatory cytokines derived from RAW 264.7 macrophage cells J Biochem 151 2012 205 216
11. S. Krishnamoorthy, A. Recchiuti, N. Chiang, S. Yacoubian, C.H. Lee, and R. Yang Resolvin D1 binds human phagocytes with evidence for proresolving receptors Proc Natl Acad Sci U S A 107 2010 1660 1665
12. C.H. Lee Resolvins as new fascinating drug candidates for inflammatory diseases Arch Pharm Res 35 2012 3 7
13. M. Mendoza, and C. Khanna Revisiting the seed and soil in cancer metastasis Int J Biochem Cell Biol 41 2009 1452 1462
14. J.R. Neil, K.M. Johnson, R.A. Nemenoff, and W.P. Schiemann Cox-2 inactivates Smad signaling and enhances EMT stimulated by TGF-beta through a PGE2-dependent mechanisms Carcinogenesis 29 2008 2227 2235
15. L.V. Norling, J. Dalli, R.J. Flower, C.N. Serhan, and M. Perretti Resolvin D1 limits polymorphonuclear leukocyte recruitment to inflammatory loci: receptor-dependent actions Arterioscler Thromb Vasc Biol 32 2012 1970 1978
16. M.K. Park, H.J. You, H.J. Lee, J.H. Kang, S.H. Oh, and S.Y. Kim Transglutaminase-2 induces N-cadherin expression in TGF-beta1-induced epithelial mesenchymal transition via c-Jun-N-terminal kinase activation by protein phosphatase 2A down-regulation Eur J Cancer 49 2013 1692 1705
17. D.M. Parkin, F. Bray, J. Ferlay, and P. Pisani Global cancer statistics, 2002 CA Cancer J Clin 55 2005 74 108 (Pubitemid 40372904)
18. H. Peinado, D. Olmeda, and A. Cano Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer 7 2007 415 428 (Pubitemid 46809165)
19. L. Prudkin, D.D. Liu, N.C. Ozburn, M. Sun, C. Behrens, and X. Tang Epithelial-to-mesenchymal transition in the development and progression of adenocarcinoma and squamous cell carcinoma of the lung Mod Pathol 22 2009 668 678
20. A. Recchiuti, and C.N. Serhan Pro-resolving lipid mediators (SPMs) and their actions in regulating miRNA in novel resolution circuits in inflammation Front Immunol 3 2012 298
21. M. Sato, D.S. Shames, A.F. Gazdar, and J.D. Minna A translational view of the molecular pathogenesis of lung cancer J Thorac Oncol 2 2007 327 343 (Pubitemid 47181718)
22. M. Sato, D.S. Shames, and Y. Hasegawa Emerging evidence of epithelial-to-mesenchymal transition in lung carcinogenesis Respirology 17 2012 1048 1059
23. J. Savill, and V. Fadok Corpse clearance defines the meaning of cell death Nature 407 2000 784 788
24. C.N. Serhan, S. Hong, K. Gronert, S.P. Colgan, P.R. Devchand, and G. Mirick Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals J Exp Med 196 2002 1025 1037 (Pubitemid 35231761)
25. F. Simiele, A. Recchiuti, D. Mattoscio, A. De Luca, E. Cianci, and S. Franchi Transcriptional regulation of the human FPR2/ALX gene: evidence of a heritable genetic variant that impairs promoter activity FASEB J 26 2012 1323 1333
26. M. Spite, L.V. Norling, L. Summers, R. Yang, D. Cooper, and N.A. Petasis Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis Nature 461 2009 1287 1291
27. P.S. Steeg Tumor metastasis: mechanistic insights and clinical challenges Nat Med 12 2006 895 904 (Pubitemid 44175140)
28. Y.P. Sun, S.F. Oh, J. Uddin, R. Yang, K. Gotlinger, and E. Campbell Resolvin D1 and its aspirin-triggered 17R epimer. Stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation J Biol Chem 282 2007 9323 9334 (Pubitemid 47104612)
29. Y. Takeyama, M. Sato, M. Horio, T. Hase, K. Yoshida, and T. Yokoyama Knockdown of ZEB1, a master epithelial-to-mesenchymal transition (EMT) gene, suppresses anchorage-independent cell growth of lung cancer cells Cancer Lett 296 2010 216 224
30. L.J. Talbot, S.D. Bhattacharya, and P.C. Kuo Epithelial-mesenchymal transition, the tumor microenvironment, and metastatic behavior of epithelial malignancies Int J Biochem Mol Biol 3 2012 117 136
31. S. Valastyan, and R.A. Weinberg Tumor metastasis: molecular insights and evolving paradigms Cell 147 2011 275 292
32. B.A. Williams, H. Sugimura, C. Endo, F.C. Nichols, S.D. Cassivi, and M.S. Allen Predicting postrecurrence survival among completely resected nonsmall-cell lung cancer patients Ann Thorac Surg 81 2006 1021 1027 (Pubitemid 43247679)
33. S.H. Wu, Y.M. Zhang, H.X. Tao, and L. Dong Lipoxin A(4) inhibits transition of epithelial to mesenchymal cells in proximal tubules Am J Nephrol 32 2010 122 136
34. R.D. Ye, F. Boulay, J.M. Wang, C. Dahlgren, C. Gerard, and M. Parmentier International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family Pharmacol Rev 61 2009 119 161